We break down the biggest tech public offering so far in 2016, messaging service Line, and discuss why it’s such an interesting IPO.

Government investigations, Forbes articles, and Twitter arguments abound – but what do Tesla Motors' competitors think of the fateful accident?

Exploring how healthcare companies create demand for their products. What’s legal, what’s not, and what are the key takeaways for investors? Joining in on today’s discussion is Brian Feroldi, a Motley Fool healthcare writers who spent more than a decade working in the industry.

We welcome Seth McNew to detail his experience at the opening ceremony and tour of UA Lighthouse, the company’s newest manufacturing facility in Baltimore, which features some of the high-tech initiatives that Kevin Plank believes will lay the foundation for his company’s future success.

Even though the Federal Reserve has been in existence for over a century, it remains a point of political contention. What is it about the Fed that makes it so controversial? And what does history tell us about the institution’s founding as well as its performance over the first century of its operation?

Roger Lowenstein, author of America’s Bank, which tells the story of the Fed’s establishment, speaks to these issues on this week’s episode of Industry Focus: Financials.

We examine the online dating space and its market share leader, Match Group.

The downturn in oil has forced companies to become even more efficient - and that means they require a lower oil price to make profits.

We compare Biogen's and Celgene's current valuations and consider what might be in store for Gilead Sciences now that its new hepatitis C drug is approved.

We talk value investing in tech to follow up our P/E episode on growth investing. Analyst John Rotonti explains some key metrics he looks at and discusses a few companies he really likes in the tech space.